Altamira Therapeutics Ltd (CYTOF)

Currency in USD
0.080
0.000(0.00%)
Delayed Data·
CYTOF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CYTOF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0800.082
52 wk Range
0.0501.340
Key Statistics
Prev. Close
0.08
Open
0.082
Day's Range
0.08-0.082
52 wk Range
0.05-1.34
Volume
2K
Average Volume (3m)
8.07K
1-Year Change
-92.92%
Book Value / Share
1.93
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CYTOF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Altamira Therapeutics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Altamira Therapeutics Ltd Company Profile

Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe. The company develops and supplies peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues through xPhore platform; and offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens It is also developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid arthritis; and AM-125 that is in post phase II clinical trial for the intranasal treatment of vertigo. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. The company was founded in 2003 and is based in Hamilton, Bermuda.

Employees
11

Compare CYTOF to Peers and Sector

Metrics to compare
CYTOF
Peers
Sector
Relationship
P/E Ratio
−0.1x−5.2x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.1x5.8x2.6x
Price / LTM Sales
-2.1x3.3x
Upside (Analyst Target)
-72.5%42.4%
Fair Value Upside
Unlock17.6%7.2%Unlock

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-1.14 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CYTOF Income Statement

People Also Watch

2.7144
KNW
+7.71%
47.120
RKLB
+1.46%
3.55
RLAY
-2.20%

FAQ

What Stock Exchange Does Altamira Therapeutics Trade On?

Altamira Therapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Altamira Therapeutics?

The stock symbol for Altamira Therapeutics is "CYTOF."

What Is the Altamira Therapeutics Market Cap?

As of today, Altamira Therapeutics market cap is 457.24K.

What Is Altamira Therapeutics's Earnings Per Share (TTM)?

The Altamira Therapeutics EPS (TTM) is -2.99.

From a Technical Analysis Perspective, Is CYTOF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Altamira Therapeutics Stock Split?

Altamira Therapeutics has split 5 times.

How Many Employees Does Altamira Therapeutics Have?

Altamira Therapeutics has 11 employees.

What is the current trading status of Altamira Therapeutics (CYTOF)?

As of 31 Jul 2025, Altamira Therapeutics (CYTOF) is trading at a price of 0.08, with a previous close of 0.08. The stock has fluctuated within a day range of 0.08 to 0.08, while its 52-week range spans from 0.05 to 1.34.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.